N
Nanwei Tong
Researcher at Sichuan University
Publications - 23
Citations - 620
Nanwei Tong is an academic researcher from Sichuan University. The author has contributed to research in topics: Diabetes mellitus & Population. The author has an hindex of 9, co-authored 22 publications receiving 381 citations.
Papers
More filters
Journal ArticleDOI
Iodine Status and Prevalence of Thyroid Disorders After Introduction of Mandatory Universal Salt Iodization for 16 Years in China: A Cross-Sectional Study in 10 Cities.
Zhongyan Shan,Lulu Chen,Xiaolan Lian,Chao Liu,Bingyin Shi,Lixin Shi,Nanwei Tong,Shu Wang,Jianping Weng,Jiajun Zhao,Xiaochun Teng,Xiaohui Yu,Yaxin Lai,Weiwei Wang,Chenyan Li,Jinyuan Mao,Yongze Li,Chenling Fan,Weiping Teng +18 more
TL;DR: The prevalence and spectrum of thyroid disorders has increased, reflecting possible adverse effects of increased iodine intake, and the prevalence of clinical hypothyroidism, subclinical hypothyroxine, and positive thyroid antibodies was significantly higher in MTAII cities than it was in AII cities.
Journal ArticleDOI
Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China
Yongze Li,Di Teng,Jianming Ba,Bing Chen,Jianling Du,Lanjie He,Xiaoyang Lai,Xiaochun Teng,Xiaoguang Shi,Yanbo Li,Haiyi Chi,Eryuan Liao,Chao Liu,Libin Liu,Guijun Qin,Yingfen Qin,Huibiao Quan,Bingyin Shi,Hui Sun,Xulei Tang,Nanwei Tong,Guixia Wang,Jin-An Zhang,Youmin Wang,Yuanming Xue,Li Yan,Jing Yang,Lihui Yang,Yongli Yao,Zhen Ye,Qiao Zhang,Lihui Zhang,Jun Zhu,Mei Zhu,Guang Ning,Yiming Mu,Jiajun Zhao,Zhongyan Shan,Weiping Teng +38 more
TL;DR: The long-term mandatory USI program with timely adjustments is successful in preventing iodine deficiency disorders and it appears to be safe, and the benefits outweigh the risks in a population with a stable median iodine intake level of up to 300 µg/L.
Journal ArticleDOI
Efficacy and safety of dulaglutide in patients with type 2 diabetes: a meta-analysis and systematic review
TL;DR: The use of dulaglutide as a monotherapy or an add-on to OAM and lispro appeared to be effective and safe for adults with type 2 diabetes mellitus.
Journal ArticleDOI
An Age-Specific Serum Thyrotropin Reference Range for the Diagnosis of Thyroid Diseases in Older Adults: A Cross-Sectional Survey in China.
Xiaodan Zhai,Le Zhang,Lulu Chen,Xiaolan Lian,Chao Liu,Bingyin Shi,Lixin Shi,Nanwei Tong,Shu Wang,Jianping Weng,Jiajun Zhao,Xiaochun Teng,Xiaohui Yu,Yaxin Lai,Weiwei Wang,Chenyan Li,Jinyuan Mao,Yongze Li,Chenling Fan,Ling Li,Zhongyan Shan,Weiping Teng +21 more
TL;DR: The serum TSH level increases with age, which may represent a normal compensatory phenomenon in older adults ≥65 years, and the use of an age-specific serum T SH reference range is recommended in Older adults for the diagnosis of thyroid diseases.
Journal ArticleDOI
Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
Shi Chen,Jia-Jun Zhao,Nanwei Tong,Xiaohui Guo,Ming-Cai Qiu,Gang-yi Yang,Zhi-min Liu,Jian-Hua Ma,Zhen-Wen Zhang,Feng Gu +9 more
TL;DR: Tolvaptan demonstrated superiority to placebo in the treatment of Chinese SIADH patients with hyponatremia by elevating serum sodium concentration with acceptable safety profile by improving urine output and proportions of patients with normalized serum sodium.